Updating the Fundamentals on Rexahn Pharmaceuticals Inc. (NYSE MKT:RNN)


Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) Return on Assets were -127.60%. At the close of the day, the stock reported a Market Cap of $100.92M in the Biotechnology Industry.

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction. Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

Recently, Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) announced that it will present preliminary data from the Phase IIa study of RX-3117 in advanced and metastatic bladder cancer at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting, which is being held June 2-6 in Chicago, Illinois.

The company traded a total volume of 2,269,056, and the stock saw a change of 7.30% in the previous trading session. The company reported a 52-Week High of $4.46% and a52-Week Low of $3254.33%. The monthly Volatility of Rexahn Pharmaceuticals, Inc. stood at 12.54%.

Rexahn Pharmaceuticals, Inc. announced EPS of $-1.14. This represents a growth of 45.70% in EPS this year compared to what was reported last financial year and represents an overall growth of 18.90% over the past five year.

Rexahn Pharmaceuticals, Inc.’s ownership was spread out with Insider Ownership amounting to 2.40% while Institutional Ownership amounted to 9.00%. Total insider transactions was -30.54% and total Institutional Transactions was 1.04%.

Return on Assets reported was -127.60%. Return on Equity for the financial year was -209.00%. Current and quick ratio amounted to 11.30 and 11.30 respectively.

The company has 23.69M shares outstanding at a price of $4.26 per share.

Rexahn Pharmaceuticals, Inc. RNN has announced a Dividend Yield of 30.05%. EPS growth reported for this year was 45.70%. For the past five years, the company has reported EPS growth of 18.90% with EPS growth for the next year projected to be -16.90%.


Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.